UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Trims Holdings in Option Care Health, Inc. $OPCH

Key Points

• UBS Asset Management reduced its holdings in Option Care Health, Inc. by 40.5%, selling over 1 million shares during the first quarter, leaving it with approximately 1.55 million shares valued at $54.2 million.
• Various institutional investors, including Northwestern Mutual and Bessemer Group, significantly increased their stakes in Option Care Health, collectively enhancing their ownership of the company.
• Despite recent insider purchases, the company's stock price has experienced a drop of 3.0%, with the latest trading price at $28.48 and a consensus price target from analysts of $35.75.

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 40.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,551,859 shares of the company's stock after selling 1,058,226 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 0.95% of Option Care Health worth $54,237,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Northwestern Mutual Wealth Management Co. increased its stake in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after purchasing an additional 836 shares during the period. Brooklyn Investment Group grew its position in shares of Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after buying an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio grew its position in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares in the last quarter. Bessemer Group Inc. grew its position in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares in the last quarter. Finally, Wealthquest Corp bought a new position in shares of Option Care Health during the 1st quarter worth $66,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction dated Wednesday, August 20th. The stock was purchased at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the purchase, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy P. Sullivan acquired 20,000 shares of Option Care Health stock in a transaction dated Thursday, August 21st. The stock was purchased at an average price of $27.51 per share, with a total value of $550,200.00. Following the completion of the purchase, the director owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 59,411 shares of company stock worth $1,627,576 over the last three months. 0.64% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Barrington Research reissued an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research report on Thursday, July 10th. Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Finally, JMP Securities increased their price target on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $35.75.

Option Care Health Trading Down 3.0%

Option Care Health stock opened at $28.48 on Monday. The stock has a 50-day moving average of $29.09 and a two-hundred day moving average of $31.42. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The stock has a market cap of $4.62 billion, a PE ratio of 22.78, a price-to-earnings-growth ratio of 1.73 and a beta of 0.83.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. During the same period last year, the business posted $0.30 earnings per share. The company's revenue for the quarter was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, research analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.